Targeted Drug Discovery in Sickle Cell Disease: From Concept to Clinic

Speaker:

Ted W. Love, M.D.

President and Chief Executive Officer (CEO), Global Blood Therapeutics

Summary of Session Goals:

The goal of this session is to provide background on PCORI and discuss comparative effectiveness research, engagement, and dissemination and implementation funding opportunities.

Learning Objectives:

1. Understand the origin and molecular basis of Sickle Cell Disease
2. Understand a potential drug discovery strategy to modify Sickle Cell Disease
3. Gain an overview of the drug development and approval process

A Live Webcast Sponsored By:

The Rockefeller University Hospital Center for Clinical and Translational Science and Clinical Directors Network, Inc. (CDN)

Date:

Wednesday, October 17, 2018 from 12:00 PM to 1:00 PM EDT

Evaluation – 

This webcast has been approved for up to 1.0 prescribed Continuing Medical Education (CME) and Continuing Nursing Education (CNE) credits by the American Academy of Family Physicians (AAFP). Please Click Here! to complete the evaluations for enduring CME Credits.

Slideset-

Targeted Drug Discovery in Sickle Cell Disease: From Concept to Clinic (PDF)

Evaluations-

This webcast is approved for up to 1.0 Prescribed CME credits by the American Academy of Family Physicians (AAFP).

Recent Webcasts

Chagas Disease as a Migrant Health Issue

 
Speakers: Alyse Wheelock, MD1, Colin Forsyth, PhD, MPH2
Introduction:
Paula Stigler Granados, PhD31Boston University,2Drugs for Neglected Diseases Initiative (DNDI),3San Diego State University
A...